Enhancement of tumor growth by drugs with some common molecular actions

This publication has 59 references indexed in Scilit:

• Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies
  JNCI Journal of the National Cancer Institute, 1995
• Inhibition of apoptosis as a mechanism of tumor promotion
  The FASEB Journal, 1994
• Enhanced Cancer Growth in Mice Administered Daily Human-Equivalent Doses of Some H1-Antihistamines: Predictive In Vitro Correlates
  JNCI Journal of the National Cancer Institute, 1994
• Tamoxifen: Trials, Tribulations, and Trade-offs
  JNCI Journal of the National Cancer Institute, 1994
• A current view of tamoxifen for the treatment and prevention of breast cancer
  British Journal of Pharmacology, 1993
• H₃ receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450
  British Journal of Pharmacology, 1992
• Intracellular histamine and liver regeneration: High affinity binding of histamine to chromatin, low affinity binding to matrix, and depletion of a nuclear storage pool following partial hepatectomy
  Biochemical and Biophysical Research Communications, 1992
• Molecular basis for binding promiscuity of antagonist drugs
  Biochemical Pharmacology, 1991
• A role for intracellular histamine in collagen-induced platelet aggregation
  Blood, 1990
• The effect of tamoxifen and estrogen receptor status on survival in gastric carcinoma
  Cancer, 1989